Cancer Treatment News and Research

RSS

Non-coding 'junk' DNA could potentially contribute to the development of cancer

Scientists have found that non-coding 'junk' DNA, far from being harmless and inert, could potentially contribute to the development of cancer.

19 Jul 2022

Caregivers for patients with multiple myeloma may suffer from anxiety and depression

Caregivers for patients with multiple myeloma may suffer from higher rates of anxiety and depression than patients themselves, according to a new study published today in Blood Advances.

18 Jul 2022

Cytokine-based cancer immunotherapy: current progress and future prospects

In this interview, News-Medical talks to Dr. Shuang Zhou about cytokine-base cancer immunotherapy, the current state of the field, and future prospects.

From Sino Biological Inc. 18 Jul 2022

Cancer treatment abandonment is widespread in Sub-Saharan Africa

Treatment abandonment is a major reason for Sub-Saharan Africa's growing cancer death rates.

14 Jul 2022

Hitting rewind on the spread of pancreatic cancer

News-Medical speaks to Linxiang Lan, a staff scientist at The Institute of Cancer Research, about a fundamental discovery that could pave way for new pancreatic cancer treatments.

14 Jul 2022

Study: Certain genetic features predispose lung cancer patients to develop immunotherapy side effects

Lung cancer is the deadliest form of cancer, accounting for an estimated 1.8 million deaths worldwide.

14 Jul 2022

NCCN publishes new guidelines for treating pediatric CNS cancers

Today, the National Comprehensive Cancer Network published new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Central Nervous System Cancers.

12 Jul 2022

Network-based machine learning method helps predict cancer patients' response to immunotherapy

Immunotherapy is a new cancer treatment that activates the body's immune system to fight against cancer cells without using chemotherapy or radiotherapy.

12 Jul 2022

In America, cancer patients endure debt on top of disease

Jeni Rae Peters would make promises to herself as she lay awake nights after being diagnosed with breast cancer two years ago.

9 Jul 2022

Scientists gain unprecedented insight into the key properties of antibody needed to combat cancer

Researchers at the University of Southampton have gained unprecedented new insight into the key properties of an antibody needed to fight off cancer.

8 Jul 2022

Study illustrates how the use of whole exome sequencing can better predict treatment response

Immunotherapies, such as immune checkpoint inhibitors, have transformed the treatment of advanced stage cancers.

8 Jul 2022

Building and retaining the expertise needed to manage cancer

The acute shortage of medical workers in oncology in Sub-Saharan Africa contributes to high rates of deaths in the region.

7 Jul 2022

Researchers find a way to kill recurring prostate cancer with a lot of iron

Prostate cancer can come back from common hormone deprivation therapy with a vengeance and no clear treatment option, but scientists have early evidence that one way to kill these recurring cancer cells may be with a lot of iron.

7 Jul 2022

Motherhood does not negatively impact a woman's chance of surviving breast cancer

Having a baby after breast cancer does not negatively impact a woman's chance of surviving the disease. A new study shows that survival is no worse in younger women, those who had not been pregnant before, and those with hormone-receptor positive breast cancer.

5 Jul 2022

Understanding the impact of bladder cancer on daily life before and after diagnosis

In this interview, Dr. Ignacio Durán and Alex Filicevas, discuss key challenges and opportunities in the bladder cancer disease landscape and the future of care. They focus on the quality of life for patients and delve into the impact bladder cancer has on daily life, both before and after diagnosis and treatment, from the holistic perspective of both patients and HCPs.

From Janssen Pharmaceuticals 4 Jul 2022

Study provides better understanding of how therapeutic resistance develops in lung cancer

New Cleveland Clinic research has uncovered key information about cellular interaction between tumor cells and normal tissue, providing better understanding of how therapeutic resistance develops.

1 Jul 2022

Big employers are offering abortion benefits. Will the information stay safe?

In response to the Supreme Court's overturning of Americans' constitutional right to abortion, large employers thought they had found a way to help workers living in states where abortions would be banned: provide benefits to support travel to other states for services. But that solution is only triggering questions.

1 Jul 2022

Cancer Treatment News and Research

Non-coding 'junk' DNA could potentially contribute to the development of cancer

Caregivers for patients with multiple myeloma may suffer from anxiety and depression

Cytokine-based cancer immunotherapy: current progress and future prospects

Cancer treatment abandonment is widespread in Sub-Saharan Africa

Hitting rewind on the spread of pancreatic cancer

Study: Certain genetic features predispose lung cancer patients to develop immunotherapy side effects

NCCN publishes new guidelines for treating pediatric CNS cancers

Network-based machine learning method helps predict cancer patients' response to immunotherapy

In America, cancer patients endure debt on top of disease

Scientists gain unprecedented insight into the key properties of antibody needed to combat cancer

Study illustrates how the use of whole exome sequencing can better predict treatment response

Building and retaining the expertise needed to manage cancer

Researchers find a way to kill recurring prostate cancer with a lot of iron

Motherhood does not negatively impact a woman's chance of surviving breast cancer

Understanding the impact of bladder cancer on daily life before and after diagnosis

Study provides better understanding of how therapeutic resistance develops in lung cancer

Big employers are offering abortion benefits. Will the information stay safe?

Scientists define plasma dose for future cancer treatments

Study finds higher risk of cardiovascular disease among adult cancer survivors

A cancer patient who had SARS-CoV-2 for over eight months

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News